What prescription topical anti‑infective skin‑care agents are available?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prescription Topical Anti-Infective Skin Care Agents

The primary prescription topical anti-infective agents available for skin care include topical antibiotics (clindamycin, erythromycin, mupirocin, fusidic acid, retapamulin), combination antibiotic products (clindamycin/benzoyl peroxide, erythromycin/benzoyl peroxide), and topical dapsone 5% gel. 1

Topical Antibiotics for Acne

For acne management, the following prescription topical antibiotics are FDA-approved:

  • Clindamycin 1% - Available as gel, lotion, solution, or foam formulations
  • Erythromycin 3% - Available in various formulations
  • Fixed-combination products that enhance compliance and reduce resistance:
    • Erythromycin 3%/benzoyl peroxide 5%
    • Clindamycin 1%/benzoyl peroxide 5%
    • Clindamycin 1%/benzoyl peroxide 3.75%

These agents target Staphylococci and Cutibacterium acnes (formerly P. acnes). 1 Clindamycin alone is pregnancy category B, with excellent tolerance, though rare reports of Clostridium difficile-related colitis exist with topical clindamycin (risk is low). 1

Critical caveat: Topical antibiotics should never be used as monotherapy due to antibiotic resistance concerns. They must be combined with benzoyl peroxide or retinoids. 2

Topical Dapsone

Dapsone 5% gel is a sulfone agent applied twice daily for inflammatory acne, showing particular efficacy in adult females. 1 It works primarily as an anti-inflammatory agent with modest to moderate efficacy in reducing inflammatory lesions. Key points:

  • Does not require glucose-6-phosphate dehydrogenase testing before initiation
  • Pregnancy category C
  • Should not be co-applied with benzoyl peroxide (causes orange-brown skin discoloration that can be washed off)
  • Approved for patients ≥12 years of age

Topical Antibiotics for Skin and Soft Tissue Infections

For impetigo and other superficial bacterial infections, prescription options include:

  • Mupirocin ointment - Applied to lesions twice daily 3, 4
  • Retapamulin ointment - Applied to lesions twice daily 3
  • Fusidic acid - Available in some regions 4

These are appropriate for patients with limited numbers of lesions. 3

Combination Corticosteroid/Antimicrobial Products

Several prescription combinations exist that pair corticosteroids with antimicrobials for inflammatory conditions with secondary infection:

Mild potency combinations:

  • Hydrocortisone 1% + clotrimazole 1% (Canesten HC)
  • Hydrocortisone 1% + miconazole 2% (Daktacort)

Moderate potency combinations:

  • Clobetasone 0.05% + oxytetracycline 3% + nystatin (Trimovate)
  • Hydrocortisone 1% + fusidic acid 2% (Fucidin H)

Potent combinations:

  • Betamethasone valerate 0.1% + fusidic acid 2% (Fucibet)
  • Betamethasone valerate 0.1% + clioquinol 3%

Very potent combinations:

  • Clobetasol propionate 0.05% + neomycin 0.5% + nystatin (Dermovate-NN)

5

Important Clinical Considerations

When prescribing topical antibiotics:

  • Use alcohol-free formulations to minimize irritation 5
  • For acne: Always combine with benzoyl peroxide or retinoids to prevent resistance
  • For wound care: Newer antiseptics (cadexomer iodine, silver dressings) are preferable to topical antibiotics, especially those available systemically 6
  • Monitor for contact dermatitis, particularly with older agents like bacitracin 4

Resistance patterns: The rising rate of antibiotic resistance is a significant challenge. Topical antibiotics should be reserved for appropriate indications and used in combination therapy when treating acne. 7, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.